While the higher TIGIT/CD226 ratio on CLL cells is reported to be typical of a more indolent disease [106], there are no other reports on the frequency of CD8+CD226+ T cells in CLL patients. This evidence concerns the gene TIGIT and B-cell chronic lymphocytic leukemia.